This webinar explores whether atrial fibrillation (AF) ablation should be recognised as the fifth pillar in the management of heart failure with atrial fibrillation.

With 30 to 50% of patients with heart failure with reduced ejection fraction (HFrEF) also affected by AF, treatment becomes increasingly complex. 

Through a case-based discussion involving a 62-year-old patient with HFrEF and AF, the panel examines patient selection, shared decision-making, anticoagulation strategies, and the role of digital tools in post-ablation care.

Key clinical trials (CASTLE-AF, CABANA, ALONE-AF), are reviewed, highlighting improvements in survival, hospitalisation rates, and quality of life. 

This session provides the evidence and practical insights needed to consider AF ablation as a core strategy in managing heart failure with atrial fibrillation. 

Watch this iHF Webinar replay if you want:

• To learn a summary of major studies (e.g., CASTLE-AF....) highlighting survival, hospitalization, and quality of life benefits in HFrEF patients
• To learn practical tools and guidelines for identifying HF patients who would benefit most from AF ablation
• To stress the importance of risk factor management and patient-centred care in HF after AF ablation